Discriminative stimulus and reinforcing effects of diclazepam in rodents
Pharmacology Biochemistry and Behavior · 2024
DOI: 10.1016/j.pbb.2023.173687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024. Verfasst von Wonjong Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry …. Hauptthemen laut MEDLINE: Rodentia, Alprazolam, Benzodiazepines. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation.
Abstract (Originalsprache)
Diclazepam, a designer benzodiazepine, is a lesser-known novel anxiolytic substance and a structural analog of diazepam. Although several case studies have reported the adverse effects of diclazepam, their potential impacts remain unknown. Therefore, this study aimed to determine the effects of diclazepam in rodents using drug discrimination, locomotor activity, self-administration (SA), and conditioned place preference (CPP) tests. Sprague-Dawley rats (male, 8 weeks old, weighing 220-450 g, n = 12 per group) and C57BL/6 mice (male, 7 weeks old, weighing 20-25 g, n = 7-8 per group) were administered alprazolam, morphine, and diclazepam. Diclazepam fully elicited alprazolam-appropriate dose-dependent lever responses (>80 %) similar to those of alprazolam. In rats administered 0.5 mg/kg of morphine, a partial substitution (80 %-20 %) was observed. Mice receiving intraperitoneal injections of diclazepam (0.05, 0.2, and 2 mg/kg) showed decreased locomotor activity. In the SA experiment, mice that self-administered intravenous diclazepam (2 μg/kg/infusion) showed significantly higher infusion and active lever responses compared to the vehicle group. No statistically significant rewarding effects of diclazepam at the doses of 0.2 and 2 mg/kg evaluated using the CPP paradigm were found. In conclusion, diclazepam has reinforcing effects and shares the interoceptive effects of alprazolam. Therefore, legal restrictions on the use of diclazepam should be carefully considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, 187 Osong Saengmyeong 2-ro, Heungdeok-gu, Chu…
- Division of in Vitro Diagnostic Devices National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, 187 Osong Saengmyeong 2-ro, Heungdeok-gu, Chungju 28159, Republic of Korea.
Förderung
- Ministry of Food and Drug Safety
- National Institute of Food and Drug Safety Evaluation
Zitieren
APA
Lee, W., Lee, J. W., Kim, S., Kim, J. M., Youn, D. H., Park, S. H., Kwon, C. H., & Choi, S. O. (2024). Discriminative stimulus and reinforcing effects of diclazepam in rodents. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173687
Vancouver
Lee W, Lee JW, Kim S, Kim JM, Youn DH, Park SH, et al. Discriminative stimulus and reinforcing effects of diclazepam in rodents. Pharmacology Biochemistry and Behavior. 2024. doi:10.1016/j.pbb.2023.173687
BibTeX
@article{Lee2024,
author = {Lee, Wonjong and Lee, Jung Won and Kim, Sungsun and Kim, Jin Mook and Youn, Dong-Hyun and Park, Seong Hye and Kwon, Chan Hyeok and Choi, Sun-Ok},
title = {Discriminative stimulus and reinforcing effects of diclazepam in rodents},
journal = {Pharmacology Biochemistry and Behavior},
year = {2024},
doi = {10.1016/j.pbb.2023.173687}
}
EUVIMED